Clinical trial
Randomized Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy
NCT00121888 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2002
- Completion date
- June 30, 2007
- Enrollment
- 60
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.